Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis

Stem cell therapy is an emerging alternative therapeutic or disease-modifying strategy for amyotrophic lateral sclerosis (ALS). The aim of this open-label phase I clinical trial was to evaluate the safety of two repeated intrathecal injections of autologous bone marrow (BM)-derived mesenchymal strom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stem Cells Transl Med
Autores principales: Oh, Ki-Wook, Moon, Chanil, Kim, Hyun Young, Oh, Sung-il, Park, Jinseok, Lee, Jun Ho, Chang, In Young, Kim, Kyung Suk, Kim, Seung Hyun
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2015
Materias:
Cell-Based Drug Development, Screening, and Toxicology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4449093/
https://ncbi.nlm.nih.gov/pubmed/25934946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2014-0212
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares